These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Raising HDL cholesterol: which is the best strategy?]. Alfonso JE; Ariza ID Rev Assoc Med Bras (1992); 2008; 54(4):369-76. PubMed ID: 18719798 [TBL] [Abstract][Full Text] [Related]
64. HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review. Kjeldsen EW; Nordestgaard LT; Frikke-Schmidt R Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925284 [TBL] [Abstract][Full Text] [Related]
65. From the editor: selling the benefit of drug therapy. Brown WV J Clin Lipidol; 2013; 7(1):1-2. PubMed ID: 23351576 [No Abstract] [Full Text] [Related]
66. Can phosphatidylserine enhance atheroprotective activities of high-density lipoprotein? Darabi M; Kontush A Biochimie; 2016 Jan; 120():81-6. PubMed ID: 26141129 [TBL] [Abstract][Full Text] [Related]
67. Regression of atherosclerosis: insights from animal and clinical studies. Feig JE Ann Glob Health; 2014; 80(1):13-23. PubMed ID: 24751561 [TBL] [Abstract][Full Text] [Related]
68. High-density lipoprotein (HDL) cholesterol - more complicated than we think? Nessler K; Windak A; Grzybczak R; Nessler MB; Siniarski A; Gajos G Ann Agric Environ Med; 2018 Sep; 25(3):517-526. PubMed ID: 30260180 [TBL] [Abstract][Full Text] [Related]
69. Human genetics of HDL: Insight into particle metabolism and function. Brunham LR; Hayden MR Prog Lipid Res; 2015 Apr; 58():14-25. PubMed ID: 25601427 [TBL] [Abstract][Full Text] [Related]
70. Good news for 'good' cholesterol. Katsnelson A Nature; 2010 Nov; 468(7322):354. PubMed ID: 21085143 [No Abstract] [Full Text] [Related]
71. HDL-C levels and cardiovascular disease: more is not always better! Mc Loughlin S; Rodríguez-Granillo GA Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):121-33. PubMed ID: 22435449 [TBL] [Abstract][Full Text] [Related]
72. New drugs for HDL-C disorders: the beginning. Duong M; Nicholls SJ Curr Med Chem; 2014; 21(25):2947-51. PubMed ID: 24735360 [TBL] [Abstract][Full Text] [Related]
73. Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients. Rysz-Górzyńska M; Banach M Arch Med Sci; 2016 Aug; 12(4):844-9. PubMed ID: 27478466 [TBL] [Abstract][Full Text] [Related]
75. Subfractions and subpopulations of HDL: an update. Rizzo M; Otvos J; Nikolic D; Montalto G; Toth PP; Banach M Curr Med Chem; 2014; 21(25):2881-91. PubMed ID: 24735362 [TBL] [Abstract][Full Text] [Related]
76. JCL roundtable: HDL in the primary care setting. Brown WV; Ansell BJ; Mackey RH; Toth PP J Clin Lipidol; 2014; 8(4):364-72. PubMed ID: 25110217 [TBL] [Abstract][Full Text] [Related]
77. The yin and yang of cholesteryl ester transfer protein in cardiovascular disease. Shah PK Circulation; 2009 Dec; 120(24):2408-10. PubMed ID: 19948970 [No Abstract] [Full Text] [Related]
78. Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions? Shao B; Heinecke JW Expert Rev Proteomics; 2018 Jan; 15(1):31-40. PubMed ID: 29113513 [TBL] [Abstract][Full Text] [Related]
79. 5th Annual International Conference on HDL Cholesterol: metabolic pathways and drug developments. Davidson WS Expert Opin Ther Targets; 2004 Aug; 8(4):359-66. PubMed ID: 15268630 [TBL] [Abstract][Full Text] [Related]